Partner
Edgar G. Engleman
Managing Partner, Chief Scientific Advisor, Vivo Capital
- Firm
- Vivo Capital
- Title
- Managing Partner, Chief Scientific Advisor
- Role
- Managing partner
- Known as
- Investor
Record updated 17 September 2026
About
Edgar Engleman, M.D. is a founding member and Chief Scientific Advisor of Vivo Capital. Dr. Engleman is a Professor of Pathology and Medicine at Stanford University School of Medicine, where he established and oversees the Stanford Blood Center, directs his immunology research team, and co-directs the Tumor Immunotherapy Program of the Stanford Cancer Institute. He is an inventor of multiple patented technologies, has authored more than 350 publications in medical and scientific journals, and trained more than 100 graduate and postgraduate students.
Background
- Education
- He received his BA from Harvard College and earned his M.D. from Columbia University School of Medicine.Source (opens in a new tab)
Is this you? Remove my profile